Stocks and Investing Stocks and Investing
Fri, June 16, 2023

Eddie Hickman Maintained (TARS) at Strong Buy with Increased Target to $42 on, Jun 16th, 2023


Published on 2024-10-28 04:24:08 - WOPRAI, Eddie Hickman
  Print publication without navigation


Eddie Hickman of Guggenheim, Maintained "Tarsus Pharmaceuticals, Inc." (TARS) at Strong Buy with Increased Target from $40 to $42 on, Jun 16th, 2023.

Eddie has made no other calls on TARS in the last 4 months.



There are 2 other peers that have a rating on TARS. Out of the 2 peers that are also analyzing TARS, 0 agree with Eddie's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Eddie


  • Francois Brisebois of "Oppenheimer" Reiterated at Buy and Held Target at $43 on, Monday, May 8th, 2023
  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Wednesday, March 15th, 2023
Contributing Sources